Recently, a family of nuclear co-repressor proteins (TRACs) have been identified that interact with thyroid hormone (TR) and retinoic acid receptors to mediate ligand-independent repression of gene transcription. In this report, we have cloned and characterized a human TRAC, which when expressed as a truncated protein lacking its repressing domains, can abolish endogenous cellular TRAC activity. Use of this inhibitor has uncovered a differential function of TRACs on negative versus positive thyroid hormone response elements and has demonstrated the importance of the TR A/B domain in modulating TRAC function. Thus, isoform-specific functions of the TR may be mediated by their functional interaction with co-repressor proteins.
Recently, a family of nuclear co-repressor proteins (TRACs) have been identified that interact with thyroid hormone (TR) and retinoic acid receptors to mediate ligand-independent repression of gene transcription. In this report, we have cloned and characterized a human TRAC, which when expressed as a truncated protein lacking its repressing domains, can abolish endogenous cellular TRAC activity. Use of this inhibitor has uncovered a differential function of TRACs on negative versus positive thyroid hormone response elements and has demonstrated the importance of the TR A/B domain in modulating TRAC function. Thus, isoform-specific functions of the TR may be mediated by their functional interaction with co-repressor proteins.
The thyroid hormone receptor (TR), 1 a member of the steroid/ thyroid hormone receptor superfamily, mediates gene regulation through its ability to bind to specific thyroid hormone response elements (TREs) (1-4) either as a monomer, homodimer, or as a heterodimer with RXR isoforms (5) (6) (7) . Through its interactions with specific TREs and other protein co-activators, the TR can either positively or negatively regulate gene expression in the presence of its ligand, triiodothyronine (T 3 ) (8 -10) . The TR also has significant ligand-independent activity in both cell culture and in vitro transcription systems (11, 12) . On positive TREs, the TR is a potent repressor of transcription in the absence of ligand (13) (14) (15) , while on negative TREs the TR activates transcription (9, 16 -18) . T 3 reverses these ligand-independent activities and causes upregulation on positive TREs and down-regulation on negative TREs. Recently, two separate proteins, termed nuclear co-repressors (TRAC), have been identified which interact with the TR in the absence of ligand to mediate ligand-independent repression on positive TREs (19 -21) . These proteins possess a carboxyl-terminal domain which mediates their interaction with the TR and amino-terminal domains, which presumably interact with the initiation complex to mediate ligand-independent repression. Their role in ligand-independent activation on negative TREs is unknown.
Further complexity in thyroid hormone signaling is mediated by the presence of 3 separate TR isoforms (␣1, ␤1, and ␤2) which activate or repress transcription in the presence of ligand (22) . The TR␤ isoforms are alternatively spliced variants which differ only in their amino terminus, while TR␣1 is the product of a separate gene but shares strong homology in its DNA and ligand binding domains but differs also in its amino terminus. Recent data from a number of different groups suggest that isoform-specific differences in both ligand-independent and -dependent activities exist on both positive and negative TREs and that these differences involve the separate amino termini which allow the TRs to either bind TREs differently, interact with members of the initiation complex with different affinities, or possess separate activation domains as is the case with the TR␤2 amino terminus (23) (24) (25) . These isoforms are also differentially expressed such that TR␤2 is primarily expressed in the hypothalamus and pituitary, suggesting that its primary role may be in mediating negative regulation by T 3 .
To explore the role of nuclear co-repressors in both negative regulation and isoform specificity, we isolated, using the yeast two-hybrid system (26, 27), 3.1 kilobases of the carboxyl-terminal portion of the human analog of NCoR originally identified by Seol et al. (19) and Horlein et al. (20) . In this study, we report that this portion of NCoR functions as a powerful dominant inhibitor of endogenous cellular co-repressor activity on TREs and substantially increases ligand-dependent negative regulation by the TR␤1 and ␣1 isoforms. However, this function was isoform-specific in that the ligand-independent and -dependent activity of the ␤2 isoform was unaffected by the presence of this inhibitor. Gel-mobility shift assays demonstrate that the ␤2 amino terminus does not impair the ability of TR␤2 to interact physically with NCoR, but a functional interaction is prevented, perhaps by coactivators which interact with the ␤2 amino terminus (25) .
MATERIALS AND METHODS
Plasmids-The positive TRE constructs each consist of two copies of DRϩ4, palindromic, or F2Lys elements upstream of the TK109 promoter in the vector pA 3 Luc (24, 28 -30) . The human TRH promoter from Ϫ900 to ϩ55 was also cloned into pA 3 Luc. Human TR␤1, ␣1, and ⌬␤␤ (from AA 102-461, deleting the amino terminus) were cloned into the SV40 driven expression vector pKCR 2 , as described previously (24) . TR␤2 was created by annealing the rat ␤2 amino terminus (a gift of M. Lazar), as an EcoRI-SacI fragment, to the human ␤1 DNA-binding and ligand-binding domains. TR␤1 mutants (E220R and AHT (A228G,H229G,T232A) were created by site-directed mutagenesis using oligonucleotides and restriction enzyme selection (31) and are identical to those made by Horlein et al. (20) . The 914-amino acid human NCoR fragment, termed NCoRI (NCoR inhibitor), was cloned into pKCR 2 and in-frame into a Gal4 DNA-binding domain (AA 1-147) containing expression vector as an EcoRI fragment. UAS-TKLuc con-* This work was supported by National Institutes of Health Grants DK-43653 and DK-49126 (to F. E. W.) and DK-02354 (to A. N. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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§ To whom correspondence should be addressed: Thyroid Unit, Research North, Rm 330, 99 Brookline Ave., Boston, MA 02215. Tel.: 617-667-2920; Fax: 617-667-2927. 1 The abbreviations used are: TR, thyroid hormone receptor; TRE, thyroid response element; RXR, retinoid X receptor; T 3 , triiodothyronine; AA, amino acid(s); Trac, thyroid hormone and retinoic acid-receptor-associated co-repressors. tains 5 copies of the 17-base pair upstream activating sequence upstream of TK luciferase (32) . The human RXR␣ cDNA was cloned into pKCR 2 . The integrity of each construct was confirmed by restriction endonuclease digestion and dideoxy sequencing. All plasmids for transfection were prepared using column (Qiagen) purification and were generally subject to two separate plasmid preparations.
Cell Culture and Transient Transfection-CV-1 cells were maintained in Dulbecco's modified Eagle's medium supplemented with Lglutamine 10% fetal calf serum, 100 g/ml penicillin, 0.25 g/ml streptomycin, and amphotericin. Transient transfections were performed using the calcium phosphate technique in 6-well plates with each well receiving 1.67 g of reporter and 83 ng of pKCR 2 -TR and/or equal amounts of pKCR 2 alone and/or equal amounts of pKCR 2 -NCoRI to determine ligand-independent and -dependent activity. 15-18 h after transfection, the cells were washed with phosphate-buffered saline and refed with Dulbecco's modified Eagle's medium with 10% steroid hormone depleted fetal bovine serum. To remove steroid and thyroid hormones, fetal bovine serum was treated for 24 h at 4°C with 50 mg/ml activated charcoal (Sigma) and 30 mg/ml anion exchange resin (type AGX-8, analytical grade, Bio-Rad). 40 -44 h after transfection, the cells were harvested in extraction buffer (33) and assayed for luciferase activity. All experiments were performed in duplicate and repeated between 2 and 4 times. The results shown are the mean Ϯ S.E.
Gel-Mobility Shift Assays-Gel-mobility shift assays were carried out using 3-4 l of in vitro translated proteins from rabbit reticulocyte lysate (Promega, Madison WI) using the pKCR 2 plasmid for each cDNA and 50,000 -75,000 cpm of a 32 P-radiolabeled DRϩ4 (5Ј-TCAGGT-CACTCTAGGTCAAC-3Ј) oligonucleotide probe. Incubations were carried out at room temperature for 20 min and complexes were resolved on 5% nondenaturing acrylamide gels followed by autoradiography. The concentration of T 3 used was 100 nM.
Yeast Two-hybrid System-A PstI-PstI cDNA fragment encoding the carboxyl-terminal amino acids (204 -461) of human TR␤1 was ligated to the EcoRI-PstI sites of pGBT9 (Clontech, Palo Alto, CA) using an EcoRI-PstI-BamHI adaptor. For screening, the yeast strain HF7c (34) was co-transfected with the thyroid hormone receptor construct and a human placental cDNA library in pGAD10 (Clontech). Transformants were plated onto synthetic complete media plates lacking histidine, leucine, and tryptophan. Viable colonies were dissolved in 40 l of Z buffer (0.06 M Na 2 HPO 4 , 0.04 M NaH 2 PO 4 , 1 mM MgSO 4 , 10 mM KCl). The colonies were then frozen in liquid nitrogen for 10 s and thawed at room temperature. This freeze-thaw step was repeated again. ␤-Galactosidase activity was measured by a chemiluminescent assay (Tropix, Bedford, MA).
Identification 
FIG. 2.
A dominant inhibitor of the nuclear co-repressor family effects ligand-independent activity of the TR in an isoform-specific fashion on positive and negative thyroid hormone response elements. CV-1 cells were cotransfected with 1.67 g of reporter and 83 ng of pKCR 2 -TR and/or 83 ng of pKCR 2 and/or 83 ng of pKCR 2 -NCoRI alone to determine ligand-independent activity and -dependent activity. TR⌬␤␤ lacks the A/B domain (24) while TRE220R and TRAHT contain amino acid changes in the hinge region (20) of TR␤1. A, ligandindependent activity was determined on the DRϩ4-luciferase reporter using a number of TR isoforms and mutants. The data are quantified as fold repression on the DRϩ4 reporter (mean Ϯ S.E.) In this case, 1 represents basal activity either in the presence of pKCR 2 alone (stippled bars) or pKCR 2 -NCoRI (black bars). B, ligand-independent activity was determined, as above, on the TRH luciferase promoter. The data are quantified as fold activation on the TRH reporter (mean Ϯ S.E.). In this case, 1 represents basal activity either in the presence of pKCR 2 alone (stippled bars) or pKCR 2 -NCoRI (black bars). C, the TRH-luciferase reporter was transfected in a similar paradigm as above with the three TR isoforms. 24 h after transfection, 10 nM T 3 was added. The data are presented as fold basal activity (mean Ϯ S.E.) where 1 (indicated by the arrow) is the basal reporter activity either in the presence of pKCR 2 alone (stippled bars) or pKCR 2 ). Isolation of yeast DNA was performed as described (35) . The resulting plasmid DNA was transformed into HB101 Escherichia coli containing a leuB mutation to allow for selection of the pGAD10 plasmid.
RESULTS AND DISCUSSION
Using the yeast two-hybrid system, as described above, we isolated a 3.1-kilobase cDNA clone from a human placental library which showed strong nucleic acid and amino acid homology to the carboxyl-terminal region of murine NCoR (20) (Fig. 1) . Functional analysis of this clone in yeast demonstrated that 1M T 3 could prevent it from interacting with the carboxyl terminus of TR␤. As this original clone contained the interacting domain of NCoR and surrounding amino acids (AA 1539 -2453), but lacked the two repressor domains present between AA 1-1120 of murine NCoR, we hypothesized that it would function as a dominant inhibitor of endogenous TRAC activity and thus termed it, NCoRI. The function of this inhibitor in eukaryotic cell lines was then tested on both positive and negative TREs.
As demonstrated in Fig. 2A , TR␤1 represses basal transcription on a positive TRE reporter containing two copies of a DRϩ4 upstream of TK109 in the absence of ligand. Co-transfection of NCoRI, as expected, competes for endogenous corepressor activity and causes ligand-independent repression to be lost and in the case of the DRϩ4 reporter leads to partial activation. Ligand-dependent activation was also blocked on the DRϩ4 reporter (expressed as fold T 3 activation) in the presence of NCoRI, primarily because of the loss of ligandindependent repression, suggesting that relief of repression is an important mechanism of thyroid hormone action (data not shown). To rule out an independent activating function of NCoRI, we cloned AA 1539 -2453 in-frame with the Gal4 DNAbinding domain and showed that it not alter expression of a UAS-TK Luc reporter construct (data not shown). NCoRI itself also had little effect on basal activity in CV-1 cells or on a cytomegalovirus promoter when co-transfected in isolation.
As we have demonstrated previously, TR␣1 is a more potent ligand-independent repressor than TR␤1 on positive TREs. Yet, as shown in Fig. 2A , co-transfection of NCoRI again competes completely for endogenous co-repressor activity on the DRϩ4 element in the presence of TR␣1. While TR␤2 is relatively weaker than the other two isoforms in ligand-independent activity on positive TREs, its activity is not appreciably changed by NCoRI. In contrast, TR⌬␤␤, which lacks the amino terminus of the TR␤ isoforms and is comparable to TR␤2 in ligand-independent activity, becomes a significant activator in the presence of co-transfected NCoRI (3-fold activation). These data indicate that TR⌬␤␤ interacts functionally with NCoRI and that the introduction of the TR␤2 amino terminus reverses this functional interaction. In addition, the TR␤1 and TR␣1 amino termini permit a functional interaction with NCoRI. Mutagenesis of the hinge region (TR␤AHT) also impairs functional interactions with NCoRI based upon its inability to bind NCoR, while TR␤E220R fully interacts with NCoRI and is known to bind the wild-type NCoR (20) . Similar results with each wild-type and mutant TR isoform were obtained on either an inverted (F2Lys) (36) or palindromic TRE (data not shown) demonstrating that the TR␤2 amino terminus blocked functional interactions with NCoRI.
To further address the functional role of the co-repressor family on thyroid hormone action, we investigated the effect of co-transfected NCoRI on the negative TREs present in the human TRH promoter. In contrast to its ligand-independent repressive activity on positive TREs, the TR causes ligandindependent activation on negative TREs. As shown in Fig. 2B , basal ligand-independent activation by both TR␤1 and TR␣1 is increased dramatically by NCoRI (from 2-fold and 1.5-fold, respectively, to 9-fold). In contrast, the 3-fold ligand-independent activation by TR␤2 is not affected by co-transfected NCoRI, consistent with its isoform-specific effect seen on the positive TREs. Similarly, TR⌬␤␤, which is a poor ligand-independent activator, becomes a potent activator (from 1.2-fold to 10-fold) in the presence of NCoRI, demonstrating that the TR␤2 amino terminus again either impairs NCoR-TR interactions or modulates the function of the repressing domains of the co-repressor family.
From these data it also appears that ligand-independent activation is important for negative regulation as increased ligand-independent effects due to co-transfected NCoRI lead to a doubling of fold repression by TRs which interact functionally with NCoRI (see upper and middle panels , Fig. 2C) ; however, fold repression is only marginally affected by NCoRI in context of TR␤2. Furthermore, as NCoRI can increase both ligandindependent activation and ligand-dependent repression of the TRH reporter construct by the TR␣1 and TR␤1 isoforms, the converse indicates that increased levels of endogenous nuclear co-repressor activity could block ligand-independent and -dependent regulation of negative TREs by these isoforms leaving TR␤2 as the only TR isoform capable of mediating negative regulation. This would be consistent with TR␤2 being expressed primarily in the thyrotroph and hypothalamus, tissues where negative regulation by T 3 is paramount (37) .
As our functional data suggest that isoform-specific interactions occur with the nuclear co-repressor family, we next asked whether the different TR isoforms could interact with NCoRI when bound to DNA. In vitro translation of the NCoRI cDNA generates a primary transcript of approximately 130 kDa consistent with its predicted size (data not shown). Incubation of in vitro translated NCoRI with in vitro translated TR␤1 in the presence of a DRϩ4 probe generates a slower migrating band (as compared to TR homodimer, lane 4, Fig. 3 ) and a diminution FIG. 3 . The nuclear co-repressor inhibitor binds to TR␤1 in a ligand-independent fashion in the presence of a TRE. Gel-mobility shift assays were carried out using 3-4 l of in vitro translated proteins from rabbit reticulocyte lysate and a 32 P-radiolabeled DRϩ4 oligonucleotide probe. The concentration of T 3 used was 100 nM. The labeled DRϩ4 probe was incubated with in vitro translated TR␤1, RXR␣, and NCoRI or unprogrammed reticulocyte lysate (UP). D, homodimer; HD, heterodimer.
in the TR homodimer, consistent with a TR␤1-NCoRI interaction. This interaction can be disrupted in the presence of 100 nM T 3 (lane 5, Fig. 3 ). Control lanes demonstrate that NCoRI does not bind the element in the absence of TR (not shown). Furthermore, TR␤2 (Fig. 4A) as well as TR␣1 (not shown) also interact with NCoRI as does TR␤E220R (Fig. 4B) . As expected, TR␤AHT does not bind NCoRI well (Fig. 4C) . These data indicate that although functional interactions between TR␤2 and NCoRI do not appear to occur, the two proteins can still physically interact on the response element consistent with the ligand-binding domain of the TR being the primary region responsible for physical interaction (20, 21) . Functionally, however, the TR␤2 amino terminus either through the recruitment of other proteins or through changes in the conformation of the TR prevents the repressing function of the nuclear co-repressor from occurring.
Analysis of the interactions between NCoRI and the TR in the gel-mobility shift assay demonstrate that NCoRI appears to principally interact with the TR homodimer or with TR monomer as the TR-RXR complex (lane 6, Fig. 3) is not altered in either intensity or position by NCoRI. Furthermore, the intensity of the TR-NCoRI band is diminished consistent with RXR competing with NCoRI for binding to the TR. To test this possibility, we performed a time course competition between TR-NCoRI and RXR. As Fig. 5 demonstrates, the addition of RXR competes effectively for the TR binding to NCoRI and diminishes the TR-NCoRI complex at every time point. These data imply that the TR-RXR heterodimer does not interact well with NCoRI in the presence of DNA in this assay, and that the interaction between TR homodimer or monomer and NCoR may be important for co-repressor activity.
In summary, we have demonstrated that endogenous nuclear co-repressor activity can be competed for with a dominant negative form of NCoR. This inhibitor, which lacks the two repressing domains, blocked ligand-independent repression by the TR on positive TREs and enhanced ligand-independent activity on negative TREs. However, co-repressor activity appears to be isoform-specific as the ligand-independent function of TR␤2 is not affected by NCoRI. This is most notably demonstrated on negative TREs where ligand-independent activation and repression by TR␤2 is not appreciably changed by NCoRI even though its physical interaction with NCoRI is maintained. Thus, the A/B domain of the TR␤2 can inactivate nuclear co-repressor function through either structural alteration or the recruitment of novel factors which modulate the function of the co-repressor.
This study supports the notion that endogenous anti-repressors may exist which could further modulate thyroid hormone and retinoic acid action in a tissue-specific fashion. Recently, an endogenous truncated isoform of the co-repressor SMRT was identified (38) . This protein appears to function as an antagonist to wild type SMRT. Further studies will be directed at identifying other isoforms of the human NCoR family. FIG. 5 . The nuclear co-repressor inhibitor (NCoRI) preferentially binds the TR homodimer. The DRϩ4 probe was incubated with TR␤1 and NCoRI. At the indicated time points during the 20-min incubation, an equal amount of RXR␣ was added. The resulting complexes were resolved on a 5% nondenaturing gel acrylamide gel followed by autoradiography. D, homodimer; HD, heterodimer.
